Robinson K M相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.

流感相关细菌继发感染期间，白细胞介素-33 在粘膜屏障处发挥新型保护作用

期刊:Mucosal Immunology

影响因子:7.6

doi:10.1038/mi.2017.32

Robinson K M, Ramanan K, Clay M E, McHugh K J, Rich H E, Alcorn J F

细胞生物学

发表日期：2018

文献求助收藏

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro

使用双特异性单链 Fv 靶向 ErbB2 和 ErbB3 可增强靶向选择性并诱导体外治疗效果

期刊:British Journal of Cancer

影响因子:6.4

doi:10.1038/sj.bjc.6604700

M K Robinson, K M Hodge, E Horak, A L Sundberg, M Russeva, C C Shaller, M von Mehren, I Shchaveleva, H H Simmons, J D Marks, G P Adams

发表日期：2008

文献求助收藏

Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study

散发性肌萎缩侧索硬化症患者的认知功能：一项为期六个月的纵向研究

期刊:Journal of Neurology Neurosurgery and Psychiatry

影响因子:7.5

doi:10.1136/jnnp.2005.073403

Robinson, K M; Lacey, S C; Grugan, P; Glosser, G; Grossman, M; McCluskey, L F

发表日期：2006

文献求助收藏

Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro

染色质、TAF 和一种新型多蛋白共激活因子是 Sp1 和 SREBP-1a 在体外协同激活所必需的。

期刊:Genes & Development

影响因子:7.7

doi:10.1101/gad.12.19.3020

Näär, A M; Beaurang, P A; Robinson, K M; Oliner, J D; Avizonis, D; Scheek, S; Zwicker, J; Kadonaga, J T; Tjian, R

发表日期：1998

文献求助收藏